Welcome to Ipswich Hospital
Our Passion, Your Care

Saturday, 16 December 2017
Ipswich Hospital continues to recruit well into national and international studies
06 August 2014
  • UKCRN 2849 Randomised controlled study to evaluate the impact of novel Glucose Sensing Technology on HbA1c in Type 2 diabetes. We were the first globally to recruit to this commercial study.
  • POD – UKCRN 16222 Prevention of Delirium (POD). We recruited the first patient to this national study.
  • CESD – UKCRN 13245 The Utility of ALT, and HDL for Identifying Lysosomal Acid Lipase Deficiency. We were the highest recruiting site for July 2014 for any of the sites since the study began.
  • BSRBR- UKCRN 7302 Biologics register of anti-TNF treated patients and prospective surveillance study for adverse. We were the highest recruiter for May 2014.
  • Import High UKCRN 2254 - Randomised Trial testing Dose Escalated Intensity Modulated Radiotherapy for Women treated by Breast Conservation Surgery and Appropriate Systemic Therapy for Early Breast Cancer. We are the highest recruiter of 51 sites for this national study.
  • BRAGGS UKCRN 5114. The team at Ipswich Hospital were the top recruiter from August 2013 to March 2014, and in May 2014.